Literature DB >> 29150712

Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease.

Alice Monzani1, Michela Perrone2, Flavia Prodam1, Stefania Moia1, Giulia Genoni3, Sara Testa2, Fabio Paglialonga2, Anna Rapa1, Gianni Bona1, Giovanni Montini2,4, Alberto Edefonti2.   

Abstract

BACKGROUND: Impairment in orexigenic/anorexigenic hormone balance may be key in the pathogenesis of protein energy wasting in children with chronic kidney disease (CKD). Measurement of ghrelin and obestatin concentrations in children with CKD would help assess the potential contribution of these hormones to uremic protein energy wasting.
METHODS: This was a cross-sectional case-control study. Acylated and unacylated ghrelin and obestatin were measured in 42 children on conservative treatment (CT), 20 children on hemodialysis, 48 pediatric renal transplant (RTx) recipients and 43 controls (CTR) (mean age 11.9, range 5-20 years). Weight, height and bicipital, tricipital, subscapular and suprailiac folds were measured, and the body mass index-standard deviation score (BMI-SDS), percentage of fat mass and fat-free mass were calculated. Urea and creatinine were measured and the glomerular filtration rate (GFR) calculated.
RESULTS: Unacylated ghrelin level was higher in patients than controls (p = 0.0001), with the highest levels found in hemodialysis patients (p = 0.001 vs. CKD-CT, p = 0.0001 vs. RTx, p < 0.0001 vs. CTR). Obestatin level was significantly higher in patients on hemodialysis than those on conservative treatment, RTx recipients and controls (p < 0.0001 in each case). Unacylated ghrelin negatively correlated with weight-SDS (p < 0.0001), BMI-SDS (p = 0.0005) and percentage fat mass (p = 0.004) and positively correlated with percentage fat-free mass (p = 0.004). Obestatin concentration negatively correlated with weight-SDS (p = 0.007). Unacylated ghrelin and obestatin concentrations positively correlated with creatinine and urea and inversely with eGFR, even after adjustments for gender, age, puberty and BMI-SDS (p < 0.0001 for each model).
CONCLUSIONS: Unacylated ghrelin and obestatin, negatively related to renal function, seem to be promising inverse indicators of nutritional status in children with CKD. Potential therapeutic implications in terms of optimization of their removal in patients on hemodialysis could be hypothesized.

Entities:  

Keywords:  Cachexia; Children; Chronic kidney disease; Ghrelin; Obestatin; Protein energy wasting

Mesh:

Substances:

Year:  2017        PMID: 29150712     DOI: 10.1007/s00467-017-3840-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  51 in total

1.  Effect of renal failure and dialysis on circulating ghrelin concentration in children.

Authors:  Kai-Dietrich Nüsken; Michael Gröschl; Manfred Rauh; Wolfgang Stöhr; Wolfgang Rascher; Jörg Dötsch
Journal:  Nephrol Dial Transplant       Date:  2004-08       Impact factor: 5.992

2.  A Biometric Study of Human Basal Metabolism.

Authors:  J A Harris; F G Benedict
Journal:  Proc Natl Acad Sci U S A       Date:  1918-12       Impact factor: 11.205

3.  Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease.

Authors:  Maria Fernanda Soares Naufel; Milena Bordon; Talita Marques de Aquino; Eliane Beraldi Ribeiro; João Tomás de Abreu Carvalhaes
Journal:  Pediatr Nephrol       Date:  2010-08-24       Impact factor: 3.714

4.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

5.  Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease.

Authors:  Anja K Büscher; Rainer Büscher; Berthold P Hauffa; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2010-07-06       Impact factor: 3.714

6.  Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; M J Gil; S Becerril; N Sáinz; C Silva; J Salvador; I Colina; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2009-02-24       Impact factor: 5.095

7.  Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men.

Authors:  Jianhua Liu; Catherine E Prudom; Ralf Nass; Suzan S Pezzoli; Mary C Oliveri; Michael L Johnson; Paula Veldhuis; David A Gordon; Andrew D Howard; Derrick R Witcher; H Mario Geysen; Bruce D Gaylinn; Michael O Thorner
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

8.  Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment.

Authors:  Damien R Ashby; Heather E Ford; Katie J Wynne; Alison M Wren; Kevin G Murphy; Mark Busbridge; Edwina A Brown; David H Taube; Mohammad A Ghatei; Frederick W K Tam; Stephen R Bloom; Peter Choi
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

Review 9.  Ghrelin: much more than a hunger hormone.

Authors:  Geetali Pradhan; Susan L Samson; Yuxiang Sun
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-11       Impact factor: 4.294

10.  Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.

Authors:  Jennifer S Temel; Amy P Abernethy; David C Currow; John Friend; Elizabeth M Duus; Ying Yan; Kenneth C Fearon
Journal:  Lancet Oncol       Date:  2016-02-20       Impact factor: 41.316

View more
  8 in total

1.  Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.

Authors:  Nur Canpolat; Lale Sever; Ayse Agbas; Mehmet Tasdemir; Cigdem Oruc; Ozlem Balcı Ekmekci; Salim Caliskan
Journal:  Pediatr Nephrol       Date:  2018-07-06       Impact factor: 3.714

Review 2.  Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch; S Russ Price
Journal:  Nat Rev Nephrol       Date:  2021-11-08       Impact factor: 42.439

3.  Unacylated ghrelin and obestatin in pediatric CKD: are they important in protein energy wasting?

Authors:  Zhen Wang; Eduardo A Oliveira; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2018-02-16       Impact factor: 3.714

Review 4.  Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives.

Authors:  Vasiliki Karava; John Dotis; Athanasios Christoforidis; Antonia Kondou; Nikoleta Printza
Journal:  Pediatr Nephrol       Date:  2021-02-03       Impact factor: 3.714

Review 5.  Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Authors:  Vanessa Shaw; Nonnie Polderman; José Renken-Terhaerdt; Fabio Paglialonga; Michiel Oosterveld; Jetta Tuokkola; Caroline Anderson; An Desloovere; Laurence Greenbaum; Dieter Haffner; Christina Nelms; Leila Qizalbash; Johan Vande Walle; Bradley Warady; Rukshana Shroff; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2019-12-16       Impact factor: 3.714

6.  Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity.

Authors:  Nataliia Vasylivna Gubina; Iryna Hryhorivna Kupnovytska; Vasyl Hryhorovych Mishchuk; Halyna Dmytrivna Markiv
Journal:  J Med Life       Date:  2020 Oct-Dec

Review 7.  Expanded haemodialysis: news from the field.

Authors:  Nans Florens; Laurent Juillard
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

8.  Predicational ability of phase angle on protein energy wasting in kidney disease patients with renal replacement therapy: A cross-sectional study.

Authors:  Haiteng Zhou; Wenlong Yao; Da Pan; Guiju Sun
Journal:  Food Sci Nutr       Date:  2021-05-07       Impact factor: 2.863

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.